Reviva Pharmaceuticals Holdings, Inc.
RVPH· OTC
RVPHReviva Pharmaceuticals Holdings, Inc.
Filed Aug 12, 2026 · 10-Q · 43 days after period end · 0001437749-26-027358
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Net Income | -$2.45M | -$6.05M | -$7.86M | -$12.44M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Reviva Pharmaceuticals Holdings, Inc. · CIK 1742927 · Engraved from SEC EDGAR
ended Jun 30, 2026 · filed Aug 12, 2026 · 43 d after period end
